NH man becomes 2nd person known to be living with a pig kidney
Mass General Brigham has announced the successful completion of another gene-edited pig kidney transplant, the first of a ...
MedPage Today3h
First Gene-Edited Pig Kidney Functioned Until Recipient's Death
The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...
FierceBiotech3h
eGenesis announces 2nd pig kidney procedure success, as xenotransplantation field moves forward
Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...
Zacks.com on MSN5h
UTHR or ZTS: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for ...
Experimental transplants with organs from gene-edited pigs see major steps forward
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received a pig kidney transplant.
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
United Therapeutics price target lowered to $460 from $475 at UBS
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...